Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.

Luo YL, Ye P, Zhang QH, Hu TT, Luo MH, Li MQ, Chen Q.

PLoS One. 2012;7(9):e46272. doi: 10.1371/journal.pone.0046272. Epub 2012 Sep 28.

2.

Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.

Zhu J, Wu L, Kohlmeier M, Ye F, Cai W.

Mol Med Rep. 2013 Sep;8(3):919-27. doi: 10.3892/mmr.2013.1589. Epub 2013 Jul 16.

PMID:
23864153
3.

MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.

Wu CY, Yang M, Lin M, Li LP, Wen XZ.

Arch Gynecol Obstet. 2013 Sep;288(3):595-605. doi: 10.1007/s00404-013-2721-3. Epub 2013 Mar 6.

PMID:
23463325
4.

Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.

Yu L, Chang K, Han J, Deng S, Chen M.

PLoS One. 2013;8(2):e55835. doi: 10.1371/journal.pone.0055835. Epub 2013 Feb 19.

5.

Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.

Wu YL, Yang HY, Ding XX, Zhao X, Chen J, Bi P, Sun YH.

Seizure. 2014 Jun;23(6):411-6. doi: 10.1016/j.seizure.2014.01.018. Epub 2014 Feb 2.

6.

The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.

Tang M, Wang SQ, Liu BJ, Cao Q, Li BJ, Li PC, Li YF, Qin C, Zhang W.

Mol Biol Rep. 2014 Jul;41(7):4659-73. doi: 10.1007/s11033-014-3337-9. Epub 2014 Apr 18.

PMID:
24744129
7.

Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.

Chen PL, Li WT, Wang J, Jiang YD, Wu P, Chen T, Zheng SB.

Genet Mol Res. 2015 Dec 29;14(4):19191-202. doi: 10.4238/2015.December.29.29.

8.

Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies.

Wu YL, Ding XX, Sun YH, Yang HY, Chen J, Zhao X, Jiang YH, Lv XL, Wu ZQ.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:78-85. doi: 10.1016/j.pnpbp.2013.06.015. Epub 2013 Jul 4.

PMID:
23831680
9.

Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.

Long S, Yang X, Liu X, Yang P.

PLoS One. 2012;7(12):e52381. doi: 10.1371/journal.pone.0052381. Epub 2012 Dec 21.

10.

Association of the MTHFR C677T polymorphism with primary brain tumor risk.

Xu C, Yuan L, Tian H, Cao H, Chen S.

Tumour Biol. 2013 Dec;34(6):3457-64. doi: 10.1007/s13277-013-0922-9. Epub 2013 Jul 12.

PMID:
23846816
11.

Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.

Fu LY, Dai LM, Li XG, Zhang K, Bai Y.

Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:56-61. doi: 10.1016/j.ejogrb.2013.10.001. Epub 2013 Oct 10. Review.

PMID:
24192663
12.

Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.

Xu XJ, Zou LW, Wang DB.

Mol Biol Rep. 2013 Jan;40(1):255-62. doi: 10.1007/s11033-012-2056-3. Epub 2012 Oct 16. Review.

PMID:
23070908
13.

Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.

Cao Y, Xu J, Zhang Z, Huang X, Zhang A, Wang J, Zheng Q, Fu L, Du J.

Gene. 2013 Feb 10;514(2):105-11. doi: 10.1016/j.gene.2012.10.091. Epub 2012 Nov 29.

PMID:
23201418
14.

The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.

Guo S, Jiang X, Chen X, Chen L, Li X, Jia Y.

Gene. 2015 Jul 1;565(1):90-5. doi: 10.1016/j.gene.2015.03.067. Epub 2015 Apr 2.

PMID:
25841988
15.

Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.

Bai R, Liu W, Zhao A, Zhao Z, Jiang D.

Mol Biol Rep. 2013 Mar;40(3):2419-30. doi: 10.1007/s11033-012-2322-4. Epub 2012 Dec 11.

PMID:
23229495
16.
17.

Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians.

Zhong S, Yang JH, Liu K, Jiao BH, Chang ZJ.

Tumour Biol. 2012 Dec;33(6):2041-51. doi: 10.1007/s13277-012-0463-7. Epub 2012 Aug 15.

PMID:
22890827
18.

The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.

Ma C, Liu Y, Zhang W, Liu P.

Mol Biol Rep. 2013 Mar;40(3):2061-8. doi: 10.1007/s11033-012-1970-8. Epub 2013 Jan 18.

PMID:
23329275
19.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151
20.

A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.

Zhong S, Chen Z, Yu X, Li W, Tang J, Zhao J.

Mol Biol Rep. 2014 Sep;41(9):5775-85. doi: 10.1007/s11033-014-3450-9. Epub 2014 Jun 29.

PMID:
24973876

Supplemental Content

Support Center